🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety, tolerability, pharmacokinetics and preli...
Status
Unknown
Location
Shanghai General Hospital
Start Date
2021-12-06
Trial ID
NCT05584306
This study aims to evaluate the immunogenicity of the drug by measuring ant...
Status
Active Not Recruiting
Location
Samsung Medical Center
Start Date
2025-08-19
Trial ID
NCT07567690
This study will examine the safety and effectiveness of a single dose of an...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2001-06
Trial ID
NCT00017862
Treatments Being Tested
Patients with severe eosinophilic asthma will be placed on biologics if the...
Status
Unknown
Location
Hannover Medical School
Start Date
2020-05-04
Trial ID
NCT04512521
Treatments Being Tested
Real-life, observational, retrospective, multicenter study to evaluate the ...
Status
Completed
Location
Azienda Ospedaliero Universitaria Ferrara
Start Date
2019-10-11
Trial ID
NCT04181190
Treatments Being Tested
This is a retrospective clinical study on adult patients (18 years or more)...
Status
Completed
Location
Helsinki University Central Hospital
Start Date
2018-01-01
Trial ID
NCT04158050
Treatments Being Tested
This study will assess the efficacy and safety of 610 as an adjunctive ther...
Status
Unknown
Location
Shanghai General Hospital
Start Date
2022-09
Trial ID
NCT05528679
Asthma affects 8% of the entire population. 4-5% of asthma sufferers have s...
Status
Unknown
Location
Nottingham Respiratory BRU
Start Date
2018-12-31
Trial ID
NCT04114396
Treatments Being Tested
This study is Safety, Tolerability and Pharmacokinetic of Recombinant anti-...
Status
Unknown
Location
Shanghai General Hospital
Start Date
2020-06-12
Trial ID
NCT04445038
The anti-interleukin-5 monoclonal antibody mepolizumab is approved as an ad...
Status
Unknown
Location
University of São Paulo
Start Date
2020-01-09
Trial ID
NCT04228588
Treatments Being Tested